2018

Signed on to OVAC letter to the House and Senate thanking them for passing BBA 2018 and asking for a high 302(b) allocation for the LHHS bill (February 21)

Signed on to OVAC letter to House and Senate asking for a minimum of a $2.144b increase for NIH in FY19 and that cancer research is made a priority (March 12)

Signed on to Ad Hoc statement in support of $39.3b for NIH in FY 2019 (April 26)

DCC 2018 Legislative Priorities letter to House and Senate asking that Congress (May 16):

Signed on to NCCS social media campaign to urge DOJ to reverse its decision in the ACA legal challenge to protect pre-existing conditions (June 18)

Signed on to ASP Coalition Letter on the Administration’s proposal to create a new Competitive Acquisition Program in Medicare Part B and move Part B drugs to Part D which would impact the number of available treatments per class (July 18)

Signed on to OVAC letter to LHHS Conferees (September 12)

Signed on to OVAC letter to Senate Leadership and Appropriations Committees thanking them for passage of another $2b increase for NIH (October 15)

Signed on to Research!America letter to House and Senate Leadership and Appropriations Committees thanking them for passage of another $2b increase for NIH (October 16)

DCC thank you to House and Senate LHHS leadership thanking them for the increases for NIH and NCI and for including report language; the letter also noted that there were differences in the report language

Written testimony to the Senate LHHS Subcommittee supporting our funding requests and report language

2017

Signed on to American Cancer Society letter to the Senate to express concern with the on-going efforts to repeal the Affordable Care Act (February 6)

Signed on to Ad Hoc letter to President Trump and Congressional Leadership to finalize FY17 funding package and include $34.1b for NIH (February 7)

DCC letter to Congress outlining our 2017 legislative priorities (March 22)

DCC letter to Congress to thank them for including a $2 billion increase for NIH in the fiscal year 2017 Consolidated Appropriations Act and to oppose the Trump Administration’s proposed cuts to NIH for FY2018. The letter also express concerns about the House passage of the American Health Care Act on May 4 (May 23)

§  DCC letter to the Senate expressing concern with the Better Care Reconciliation Act because it allows states to change what qualifies as an essential health benefit (June 27)

§  DCC letters to Representatives Cole and DeLauro (House LHHS Chair and Ranking member) thanking them for crafting a House bill that makes medical research a priority (July 17)

§  DCC letter to Senate Appropriations Committee thanking them for including a $2b increase for NIH in their bill and asking that they move forward on a budget deal (October 31)

§  Signed on to OVAC letter to House and Senate Leadership to raise the FY18 budget caps (November 1)

§  Signed on to Ad Hoc letter to Congressional leadership to ask that they include the $2b increase for NIH included in the Senate Appropriations Committee’s FY18 LHHS bill (November 2)

§  DCC letter to Dr. Ned Sharpless congratulating him on becoming NCI Director (November 30)

§  Signed NORD letter to Members of the Tax Cuts and Jobs Act Conference Committee requesting that the Orphan Drug Tax Credit be preserved in the final tax bill (December 7)

February 2017 Community sign-on letter on pre-existing health conditions 

March 2017 Letter on Priorities for the 115th Congress

May 2017 Letter Thanking Congress for FY17 $2 billion increase for NIH and expressing concern about House-passed AHCA

June 2017 Letter to Senate expressing concern with the Better Care Reconciliation Act of 2017